Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Gregory Makris, Senior Director in Global Medical Affairs, Cardiovascular and Thrombosis at Bayer, shared on LinkedIn:
”Stroke medicine is evolving rapidly, with emerging evidence continuously informing clinical practice!
A few days after the release of the OCEANIC Stroke trial, it is great to see Factor XI making it to the European Stroke Organisation annual stroke evidence update for 2025!
There is no time to lose when it comes to preventing secondary strokes!”
Title: ESO annual stroke evidence update 2025
Authors: Diana Aguiar de Sousa, Aristeidis H Katsanos, Linxin Li, Nicolas Martinez-Majander, John McCabe, Lina Palaiodimou, Anna Ramos Pachon, Michele Romoli, Peter D Schellinger, Annaelle Zietz, Sven Poli, Melinda Roaldsen, Ashkan Shoamanesh, Marek Sýkora, Georgios Tsivgoulis
Read the Full Article on European Stroke Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?